COMBINATIONS OF BLOOD GROUP AFFILIATION AND IL-28B GENOTYPES IMPACT THE OUTCOMES OF PEG-IFN±-2/RBV HCV-1 TREATMENT AND LIVER FIBROSIS IN NONRESPONDERS ArticleOgurtsov P., Kukhareva E., Tarasova O.Indian Journal of Gastroenterology. Vol. Vol 35. 2016. P.. 56-56
